SARS

New study supports UK delay of second dose of Pfizer SARS-CoV-2 vaccine

The Alzheimer’s risk gene can increase the vulnerability and severity of COVID-19

Predicting future mum guests of SARS-CoV-2

Hematologic results in Amazonian patients with COVID-19

Nasodine antiseptic nasal spray shows potential antiviral activity against SARS-CoV-2

An idea of ​​the role of aging in response to SARS-CoV-2 infection

The COVID-19 vaccine should be recommended for patients with Parkinson’s disease, experts say

The Pfizer-BioNTech vaccine shows promise against new SARS-CoV-2 modifications

The antiviral compound GC-376 shows efficacy against SARS-CoV-2 in vivo

Researchers in Japan compare two seroprevalence antibody tests for SARS-CoV-2